-
1
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors
Published 2025-03-01Subjects: “…Anaplastic lymphoma kinase (ALK)…”
Get full text
Article